The next generation OCT2 Module is able to detect the retinal and choroid blood flow without the need to inject any dye and analyse layer by layer using the en-face visualisation. It provides three-dimensional reconstruction of the perfused microvasculature within the retina and choroid. According to Prof. Gabriel Coscas of the University of Paris, “The clinical potential of this new technology is tremendous”.
Key for this technology is the high-resolution Spectralis OCT scans combined with active eye tracking and scan registration. With the Expandable Spectralis Diagnostic Imaging Platform you can add the new diagnostic capabilities when you’re ready.
Pictured here is a depth selective OCT Angiography providing structural detail of the retinal vasculature without dye injection.
Contact Heidelberg: (AUS) 03 9639 2125 or (NZ) 09 443 0072
[/vc_column_text][/vc_column]
